Perrigo Company plc Goodwill, Transfers
Perrigo Company plc (PRGO) reported Goodwill, Transfers of -$108.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillTransfers · last filed 2026-02-26
- Perrigo Company plc goodwill, transfers for the quarter ending 2025-12-31 was -$224.80M.
- Perrigo Company plc goodwill, transfers for the quarter ending 2017-09-30 was -$28.60M, a 735.56% decline year-over-year.
- Perrigo Company plc goodwill, transfers for the quarter ending 2016-12-31 was -$2.70M.
- Perrigo Company plc goodwill, transfers for the quarter ending 2016-10-01 was $4.50M.
- Perrigo Company plc goodwill, transfers for fiscal 2025 was -$108.60M.
- Perrigo Company plc goodwill, transfers for fiscal 2016 was $13.50M.
| Period end | Goodwill, Transfers 3 month | Goodwill, Transfers 6 month | Goodwill, Transfers 6 month as first filed | Goodwill, Transfers 9 month | Goodwill, Transfers 9 month as first filed | Goodwill, Transfers 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$224.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$108.60M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $116.20M 10-Q · filed 2025-11-05 | |||||
| 2024-06-29 | $93.10M 10-Q · filed 2024-08-02 | |||||
| 2017-09-30 | -$28.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$32.60M 10-Q · filed 2017-11-09 | ||||
| 2017-07-01 | -$4.00M 10-Q · filed 2017-08-10 | |||||
| 2016-12-31 | -$2.70M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $1.80M derived: sum of 2 quarters · filed 2018-03-01 | $5.00M derived: sum of 3 quarters · filed 2018-03-01 | $13.50M 10-K · filed 2018-03-01 | ||
| 2016-10-01 | $4.50M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-05-23 | $7.70M derived: sum of 2 quarters · filed 2017-05-23 | $16.20M 10-Q/A · filed 2017-05-23 | $24.70M 10-Q · filed 2016-11-10 | ||
| 2016-07-02 | $3.20M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $11.70M 10-Q/A · filed 2017-05-22 | ||||
| 2016-04-02 | $8.50M 10-Q/A · filed 2017-05-22 | |||||
| 2015-12-31 | -$27.60M 10-K · filed 2018-03-01 | -$27.50M 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |